Danaher Corp
DHRToday
-1.60%
5 Days
-3.89%
1 Month
+3.84%
6 Months
+6.67%
Year to Date
-8.91%
1 Year
+4.49%
Danaher Corp Stock (DHR) Moved Down by 3.06% on Sep 1: Facts Behind the Movement
• Danaher narrowed its full-year core revenue growth projections following second-quarter results. • Outgoing leadership announced a transition alongside subsequent disclosures of executive share sales. • The company reported latest annual revenue of $24.57B and net profit of $3.61B.
Danaher Corp Stock (DHR) Closed Up by 6.16% on Aug 19: A Full Analysis
• Danaher reported second-quarter revenue and adjusted earnings exceeding Wall Street consensus estimates. • Julie Sawyer Montgomery was appointed as the new chief executive officer. • Danaher generated $24.57B in annual revenue with $3.61B in net profit.
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.67% on Aug 19: Facts Behind the Movement
• Thermo Fisher raised its full-year outlook following strong second-quarter financial results. • The company sold its microbiology business to Astorg for over one billion dollars. • Institutional managers and hedge funds recently built fresh positions in the company.
Thermo Fisher Scientific Inc Stock (TMO) Closed Up by 3.20% on Jul 28: Drivers Behind the Movement
• Thermo Fisher exceeded quarterly earnings estimates and raised full-year organic revenue guidance. • Increased pharmaceutical capital expenditure and demand for clinical services boosted the company's backlog. • Technical indicators suggest a buy signal with an average analyst price target of $634.52.
Stryker Corp Stock (SYK) Closed Up by 3.21% on Jul 23: Drivers Behind the Movement
• Stryker’s second-quarter earnings exceeded analyst expectations with growth in MedSurg and Neurotechnology. • Management raised full-year earnings guidance citing strong demand and elective procedure recovery. • Analysts increased price targets following positive performance and consistent robotic technology market expansion.
Danaher Corp Stock (DHR) Moved Up by 6.78% on Jul 23: What Signal Does It Send?
• Danaher’s quarterly earnings surpassed analyst expectations, driving a rise in the company’s stock price. • Bioprocessing demand has normalized, signaling a recovery in the company’s biotechnology and life sciences segments. • Management raised full-year earnings and revenue guidance, citing sustainable growth in core business units.
Danaher Corp's Score
Media Coverage
Analyst Rating
Danaher Corp Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Danaher Corp Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Rales (Steven M) | 5.97% |
| Vanguard Capital Management, LLC | 5.81% |
| Rales (Mitchell P) | 4.66% |
| BlackRock Institutional Trust Company, N.A. | 4.12% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 46.09% |
| Investment Advisor/Hedge Fund | 25.78% |
| Individual Investor | 10.69% |
| Hedge Fund | 2.99% |
Related Instruments
Popular Instruments
